QUETIAPINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Quetiapine, and what generic alternatives are available?
Quetiapine is a drug marketed by Accord Hlthcare, Alignscience Pharma, Amneal Pharms, Aurobindo Pharma, Lupin, Macleods Pharms Ltd, Novast Labs, Ph Health, Pharmadax, Platinum, Prinston Inc, Rising, Sciegen Pharms, Unichem, Actavis Grp Ptc, Alembic, Alkem Labs Ltd, Aurobindo Pharma Ltd, Chartwell Rx, Hetero Labs Ltd V, Hikma, Ipca Labs Ltd, Jubilant Generics, Lupin Ltd, Pharmobedient, Sun Pharm, Teva Pharms, and Torrent Pharms Ltd. and is included in thirty-eight NDAs.
The generic ingredient in QUETIAPINE is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quetiapine
A generic version of QUETIAPINE was approved as quetiapine fumarate by ACCORD HLTHCARE on March 27th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUETIAPINE?
- What are the global sales for QUETIAPINE?
- What is Average Wholesale Price for QUETIAPINE?
Summary for QUETIAPINE
| US Patents: | 0 |
| Applicants: | 28 |
| NDAs: | 38 |
| Drug Prices: | Drug price information for QUETIAPINE |
| Drug Sales Revenues: | Drug sales revenues for QUETIAPINE |
| DailyMed Link: | QUETIAPINE at DailyMed |
US Patents and Regulatory Information for QUETIAPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 202152-001 | Mar 27, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Ltd | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 091388-004 | Mar 27, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmadax | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 206260-005 | May 9, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
